Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice

Risperidone, a second-generation antipsychotic drug used for schizophrenia treatment with less-severe side effects, has recently been applied in major depressive disorder treatment. The mechanism underlying risperidone-associated metabolic disturbances and liver and renal adverse effects warrants fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hsiao-Pei, Hou, Po-Hsun, Mao, Frank-Chiahung, Chang, Chia-Chia, Yang, Wei-Cheng, Wu, Ching-Feng, Liao, Huei-Jyuan, Lin, Tzu-Chun, Chou, Lan-Szu, Hsiao, Li-Wei, Chang, Geng-Ruei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795724/
https://www.ncbi.nlm.nih.gov/pubmed/33401717
http://dx.doi.org/10.3390/ijms22010409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795724/
https://www.ncbi.nlm.nih.gov/pubmed/33401717
http://dx.doi.org/10.3390/ijms22010409

Ejemplares similares